Brenda Mann - Aug 3, 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
VP of Research & Development
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Aug 3, 2021
Transactions value $
-$151
Form type
4
Date filed
8/4/2021, 05:45 PM
Previous filing
Jul 6, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$151 -63 -0.41% $2.40 15.3K Aug 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021.